Cisplatin-monotherapy in the Treatment of BRCA1 Positive Breast Cancer Patients in Poland
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: BRCA1 Mutation|Breast Cancer Invasive Nos
Interventions: DRUG: Neoadjuvant Cisplatin Chemotherapy
Sponsor: Pomeranian Medical University Szczecin
Collaborators: Maria Sklodowska-Curie National Research Institute of Oncology|Regional Oncology Hospital, Bielsko-Biala, Poland